BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16088464)

  • 1. Zygomycosis.
    Freifeld AG; Iwen PC
    Semin Respir Crit Care Med; 2004 Apr; 25(2):221-31. PubMed ID: 16088464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreaks of zygomycosis in hospitals.
    Antoniadou A
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():55-9. PubMed ID: 19754759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among zygomycetes.
    Reinhardt DJ; Licata I; Kaplan W; Ajello L; Chandler FW; Ellis JJ
    Sabouraudia; 1981 Dec; 19(4):245-56. PubMed ID: 6798698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of zygomycosis--Absidia, Rhizopus, Rhizomucor, and Cunninghamella.
    Kamei K
    Mycopathologia; 2001; 152(1):5-13. PubMed ID: 11694096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zygomycosis--a case report and overview of the disease in India.
    Diwakar A; Dewan RK; Chowdhary A; Randhawa HS; Khanna G; Gaur SN
    Mycoses; 2007 Jul; 50(4):247-54. PubMed ID: 17576314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
    Gil-Lamaignere C; Simitsopoulou M; Roilides E; Maloukou A; Winn RM; Walsh TJ
    J Infect Dis; 2005 Apr; 191(7):1180-7. PubMed ID: 15747255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
    Narreddy S; Manavathu E; Chandrasekar PH; Alangaden GJ; Revankar SG
    J Antimicrob Chemother; 2010 Apr; 65(4):701-3. PubMed ID: 20130026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress response in medically important Mucorales.
    Singh P; Paul S; Shivaprakash MR; Chakrabarti A; Ghosh AK
    Mycoses; 2016 Oct; 59(10):628-35. PubMed ID: 27292160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of zygomycete species identified in clinically significant specimens in the United States.
    Alvarez E; Sutton DA; Cano J; Fothergill AW; Stchigel A; Rinaldi MG; Guarro J
    J Clin Microbiol; 2009 Jun; 47(6):1650-6. PubMed ID: 19386856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
    Simitsopoulou M; Georgiadou E; Walsh TJ; Roilides E
    Med Mycol; 2010 Aug; 48(5):720-4. PubMed ID: 20100138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zygomycetes and zygomycosis in the new era of antifungal therapies].
    Torres-Narbona M; Guinea J; Muñoz P; Bouza E
    Rev Esp Quimioter; 2007 Dec; 20(4):375-86. PubMed ID: 18563211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity iron permease (FTR1) gene sequence-based molecular identification of clinically important Zygomycetes.
    Nyilasi I; Papp T; Csernetics A; Krizsán K; Nagy E; Vágvölgyi C
    Clin Microbiol Infect; 2008 Apr; 14(4):393-7. PubMed ID: 18190575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 7: zygomycosis.
    Severo CB; Guazzelli LS; Severo LC
    J Bras Pneumol; 2010; 36(1):134-41. PubMed ID: 20209316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary zygomycosis.
    Pyrgos V; Shoham S; Walsh TJ
    Semin Respir Crit Care Med; 2008 Apr; 29(2):111-20. PubMed ID: 18365993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zygomycetes in human disease.
    Ribes JA; Vanover-Sams CL; Baker DJ
    Clin Microbiol Rev; 2000 Apr; 13(2):236-301. PubMed ID: 10756000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous zygomycosis: a possible postoperative complication in immunocompetent individuals.
    Tilak R; Raina P; Gupta SK; Tilak V; Prakash P; Gulati AK
    Indian J Dermatol Venereol Leprol; 2009; 75(6):596-9. PubMed ID: 19915241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease.
    Dekkers R; Verweij PE; Weemaes CM; Severijnen RS; Van Krieken JH; Warris A
    Med Mycol; 2008 Aug; 46(5):491-4. PubMed ID: 18608916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.
    Dannaoui E; Mouton JW; Meis JF; Verweij PE;
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1953-9. PubMed ID: 12019114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Zygomycosis caused by Cunninghamella bertholletiae in a child with acute lymphoblastic leukemia.
    Bibashi E; Sidi V; Kotsiou M; Makrigiannaki E; Koliouskas D
    Hippokratia; 2008 Jan; 12(1):43-5. PubMed ID: 18923760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.